bioRxivImmunologyPreprint
Programmed cell death-1 receptor mediated regulation of Tbet+ NK1.1- Innate Lymphoid Cells within the Tumor Microenvironment
M. Lim, C. Lai, G. Mallett, D. McDonald, G. Hulme, S. Laba, A. Shapanis, M. Payne, W. Patterson, M. Alexander, J. Coxhead, A. Filby, R. Plummer, P. Lovat, G. Sciume, E. Healy, S. Amarnath
Abstract
Innate Lymphoid Cells (ILCs) play a key role in tissue mediated immunity and can be controlled by co-receptor signaling. Here we define a subset of ILCs that are Tbet+NK1.1- and are present within the tumor microenvironment (TME). We show programmed death-1 receptor (PD-1) expression on ILCs within TME is found in Tbet+NK1.1-ILCs. PD-1 significantly controlled the proliferation and function of Tbet+NK1.1-ILCs in multiple murine and human tumors. We found tumor derived lactate enhanced PD-1 expression on Tbet+NK1.1-ILCs within the TME, which resulted in dampened mTOR signaling along with increased fatty acid uptake. In line with these metabolic changes, PD-1 deficient Tbet+NK1.1-ILCs expressed significantly increased IFN{gamma}, granzyme B and K. Furthermore, PD1 deficient Tbet+NK1.1- ILCs contributed towards diminished tumor growth in an experimental murine model of melanoma. These data demonstrate that PD-1 can regulate anti-tumor responses of Tbet+NK1.1-ILCs within the tumor microenvironment. HighlightsO_LITbet+NK1.1- ILCs are found in WT and PD1 ko mice C_LIO_LIPD-1 is expressed on Tbet+NK1.1- ILC1s within multiple TME C_LIO_LIPD-1 controls the proliferation and function of Tbet+NK1.1- ILCs within the tumor microenvironment by modulating fatty acid metabolism. C_LIO_LIPD-1 regulates the proliferation of human Tbet+ ILC1s in human cutaneous squamous cell carcinoma (cSCC) and melanoma tumor microenvironment. C_LI
- organism: mouse
- organism: human
- assay: bulk RNA-seq
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: metabolism & bioenergetics
- approach: experimental assay
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tumor PD-L1 selectively suppresses type I interferon in myeloid cells to suppress CTL recruitment to promote lung metastasis
J. D. Klement, P. S. Redd, … K. Liu·bioRxiv·Jun 18, 2021
- Lymphatic PD-L1 expression restricts tumor-specific CD8+ T cell responses
N. Cousin, S. Cap, … L. Dieterich·bioRxiv·Oct 22, 2020
- The PD-L1/PD-1 Axis Blocks Neutrophil Cytotoxicity In Cancer
M. Gershkovitz, O. Yajuk, … Z. Granot·bioRxiv·Feb 28, 2020
- When killers become thieves: trogocytosed PD-1 inhibits NK cells in cancer
M. S. Hasim, M. Marotel, … M. Ardolino·bioRxiv·Jun 26, 2020
- PD-L1ATTAC mice reveal the potential of targeting PD-L1 expressing cells in cancer therapy
E. Fueyo-Marcos, C. Fustero-Torre, … M. Murga·bioRxiv·Jul 22, 2022
- Inflammasome- and gasdermin D-independent IL-1β production mobilizes neutrophils to inhibit antitumor immunity
M. Kiss, L. Vande Walle, … D. Laoui·bioRxiv·Aug 4, 2020